1. Is schizophrenia hereditary? Heredity is the most important risk factor for schizophrenia. Familial studies have found that the prevalence of the disease among first-degree relatives of patients with the disease is several times higher than in the general population, and the closer the blood relationship, the higher the incidence. When patients are planning to have children, they should undergo genetic counseling and the genetic counselor should make individualized medical recommendations to reduce or prevent the transmission of the disease after a comprehensive assessment of their genetic risk. 2.Can I get married if I have schizophrenia? If the patient’s condition has been well controlled after treatment and is not in the onset of schizophrenia, it is possible to get married. However, it should be noted that Article 9 of the Law of the People’s Republic of China on Maternal and Child Health stipulates that: after premarital medical examination, the physician shall give a medical opinion if the patient is suffering from a designated infectious disease during the infectious period or the onset of the relevant mental illness; the man and woman who are planning to get married shall suspend the marriage. Relevant mental illness, refers to schizophrenia, manic-depressive psychosis, and other heavy mental illness. 3.If I want to have children and breastfeed, should I pay attention to anything? (1) Patients of childbearing age are generally advised to avoid pregnancy and childbirth when their psychiatric symptoms are obvious, declining, or when they are taking high doses or drugs that have a large impact on the fetus. If a pregnancy is unexpected under the above circumstances, first consider terminating the pregnancy; if both parties have suffered from schizophrenia, it is recommended to avoid childbirth. (2) Women with schizophrenia who have had no relapse for more than 2 years may try to stop medication for pregnancy; patients with stable disease may consider stopping medication in the 1st~3rd month of pregnancy, and starting from the 4th month of pregnancy, start taking the original treatment medication, starting with small doses and gradually increasing the dosage, striving to achieve the purpose of consolidating the therapeutic effect with the smallest dosage. In the 1-2 months before delivery, patients need to take medication to prevent the relapse of the disease before and after delivery, but attention must be paid to the effect of medication on the fetus before and after delivery. (3) The therapeutic dose should be increased appropriately after delivery, and for patients who have not maintained treatment, a full dose of medication should be given as soon as possible after delivery. Breastfeeding women receiving psychotropic medication should review the pros and cons of medication and breastfeeding. If the condition is stable, it is recommended that medication be discontinued during breastfeeding, and if the condition requires it, breastfeeding may be appropriate when receiving low-dose medication.